Gossamer Bio, Inc. (GOSS) — Financial statements
Income statement, balance sheet, and cash flow for Gossamer Bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 48↓57.7% | 115 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 1 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 47↓58.6% | 115 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 174↑25.7% | 138↑2.4% | 135↓20.8% | 171↑0.4% | 170 | |
| General & Administrative Expenses | 38↑4.1% | 36↓6.0% | 38↓19.2% | 48↑4.0% | 46 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 38↑4.1% | 36↓6.0% | 38↓19.2% | 48↑4.0% | 46 | |
| Other Expenses | -1 | 0.00↓100.0% | 10↑15284.6% | 0.07↓13.3% | 0.08 | |
| Operating Expenses | 211↑20.7% | 175↓5.0% | 184↓15.9% | 219↑1.1% | 216 | |
| Total Costs & Expenses | 212↑21.2% | 175↓5.0% | 184↓15.9% | 219↑1.1% | 216 | |
| Operating Results | ||||||
| Operating Income | -163↓172.5% | -60↑67.4% | -184↑15.9% | -219↓1.1% | -216 | |
| Depreciation & Amortization | 1↓75.9% | 4↓5.3% | 4↓1.0% | 4↓14.3% | 5 | |
| EBITDA | -162↓306.0% | -40↑75.3% | -162↑23.3% | -211↓0.8% | -209 | |
| EBIT | -163↓270.0% | -44↑73.5% | -166↑22.8% | -215↓0.4% | -215 | |
| Interest & Other Income | ||||||
| Net Interest Income | -9↑7.4% | -10↑15.4% | -12↑6.4% | -12↑34.2% | -19 | |
| Interest Income | 2↑10.7% | 2↓10.9% | 2↑26.2% | 2↑108.0% | 0.76 | |
| Interest Expense | 11↓4.6% | 12↓14.8% | 14↓2.7% | 14↓28.6% | 19 | |
| Non-Operating Income | 0.00↑100.0% | -16↑9.5% | -17↓463.9% | -3↓98.4% | -2 | |
| Other Income / Expenses | -7↓268.2% | 4↑8.7% | 4↑136.6% | -11↑39.7% | -18 | |
| Income Before Tax | -170↓206.4% | -56↑69.1% | -180↑21.6% | -229↑2.0% | -234 | |
| Income Tax Expense | -0.09↓109.9% | 0.89 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -170↓201.4% | -57↑68.6% | -180↑21.6% | -229↑2.0% | -234 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -170↓201.4% | -57↑68.6% | -180↑21.6% | -229↑2.0% | -234 | |
| Bottom-Line Net Income | -170↓201.4% | -57↑68.6% | -180↑21.6% | -229↑2.0% | -234 | |
| EPS (Basic) | -0.75↓200.0% | -0.25↑68.8% | -0.80↑71.8% | -2.84↑14.7% | -3.33 | |
| EPS (Diluted) | -0.75↓200.0% | -0.25↑78.8% | -1.18↑58.5% | -2.84↑14.7% | -3.33 | |
| Weighted Average Shares | 229↑1.0% | 226↑0.3% | 226↑166.7% | 85↑13.0% | 75 | |
| Weighted Average Diluted Shares | 229↑1.0% | 226↑0.3% | 226↑166.7% | 85↑13.0% | 75 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.